Advertisement

KHN

Democrats Eye Medicare Negotiations to Lower Drug Prices

Progressive and conservative Democratic lawmakers, as well as President Joe Biden, are in favor of authorizing federal officials to negotiate with drugmakers over what Medicare pays for at least some of the most expensive brand-name drugs and to base those prices on the drugs’ clinical benefits. Such a measure could put Republicans in the uncomfortable position of opposing an idea that most voters from both parties generally support.

Read More

Under New Cost-Cutting Medicare Rule, Same Surgery, Same Place, Different Bill

A Trump administration Medicare rule will push some hospital patients into a Catch-22: The government says several hundred procedures no longer need to be done in a hospital, but it did not approve them to be performed elsewhere. So patients will still need to use a hospital while not officially admitted — and may be charged more out-of-pocket for the care.

Read More

So You’re Vaccinated Against Covid. Now What?

The vaccination rollout has been unsteady, but the vaccines seem very effective, raising hopes that the pandemic will subside by later this year if enough Americans get their shots. Meanwhile, remain cautious.

Read More

KHN’s ‘What the Health?’: ACA Packs More Benefits — And More Confusion

The covid relief bill signed by President Joe Biden includes a long list of new health benefits for consumers. But many eligible people may have difficulty taking advantage of them because of the interaction with the income tax system and a lack of expert guidance. Meanwhile, Democrats are debating internally about what should come next on the health agenda. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more.

Read More

For latest news and updates
Email-id is invalid